Hepatic manifestations of women with polycystic ovary syndrome.
about
Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss.Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis.Eicosapentaenoic Acid Improves Polycystic Ovary Syndrome in Rats via Sterol Regulatory Element-Binding Protein 1 (SREBP-1)/Toll-Like Receptor 4 (TLR4) Pathway.
P2860
Hepatic manifestations of women with polycystic ovary syndrome.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Hepatic manifestations of women with polycystic ovary syndrome.
@en
type
label
Hepatic manifestations of women with polycystic ovary syndrome.
@en
prefLabel
Hepatic manifestations of women with polycystic ovary syndrome.
@en
P1476
Hepatic manifestations of women with polycystic ovary syndrome.
@en
P304
P356
10.1016/J.BPOBGYN.2016.03.003
P577
2016-04-06T00:00:00Z